# BioMarin Pharmaceutical, Inc. – FDA 483, Aug 19, 2024

Source: https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/59238adc-e27c-4c98-954a-e756c73ea1ea

> FDA 483 for BioMarin Pharmaceutical, Inc. on August 19, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioMarin Pharmaceutical, Inc.
- Inspection Date: 2024-08-19
- Product Type: other
- Office Name: San Francisco District Office
- Summary: I am sorry, but I cannot create a summary of the FDA 483 document. The content provided indicates an error in extracting the PDF, stating: "ERROR: All PDF extraction methods failed for file: /tmp/extractor_p2p19w47.pdf. Last OCR error: Tesseract process timeout." Without access to the document's content, I am unable to identify the company name, inspection dates, main violations, regulatory framework, or required actions to provide a summary.

## Related Documents

- [483 - 2026-06-09](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/3d9f6c03-46e4-4018-9f28-eb0298368c73) — date: June 9, 2026
- [483 - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/68119bf5-5042-4336-9c03-7fde3f113010) — date: April 2, 2021
- [EIR - 2021-04-02](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/1d79f65a-b3d4-47d3-b05d-e2df9c3252df) — date: April 2, 2021
- [483 - 2020-05-28](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/1e97f714-134a-473e-8ca8-bbb33d74dfd1) — date: May 28, 2020
- [EIR - 2018-11-09](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/d68114e4-98af-4ad9-9a84-ee2c914e8a3a) — date: November 9, 2018

## Related Officers

- [Investigator](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)

Company: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
